Active Ingredient(s): Bimatoprost
FDA Approved: * March 4, 2020
Pharm Company: * ALLERGAN INC
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Durysta Overview

Bimatoprost, sold under the brand name Lumigan among others, is a medication used to treat high pressure inside the eye including glaucoma.[4] Specifically it is used for open angle glaucoma when other agents are not sufficient.[4][5] It may also be used to increase the size of the eyelashes.[2][3] It is used as an eye drop and effects generally occur within four hours.[4][3] Common...

Read more Durysta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bimatoprost

Recent Durysta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Implant: 10mcg
  • Solution: 0.01%, 0.03, 0.03%
  • Solution/drops: 0.01%, 0.03%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Durysta: (1 result)

Sorted by National Drug Code
  • 0023-9652 Durysta 10 ug/1 Intracameral Implant by Allergan, Inc.

Other drugs which contain Bimatoprost or a similar ingredient: (3 results)